Berkeley SKYDECK

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs

13 Jan 2026

Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs

Allos AI applies causal AI to reformulate complex generic drugs, improving delivery, tolerability and predictability while reducing development uncertainty.

Berkeley SKYDECK

- Life Sciences
1(12 months)
skydeck.berkeley.edu
Update Information

More venture news

Noggin HQ
19 Aug 2026
Noggin HQ secures £2.3 million led by Blackfinch Ventures for a credit reference agency built on open banking data
SeedFintech
Twin1
20 Aug 2026
Twin1 AI lands a £15m seed round co-led by VC investors to pair professionals with their own digital twin
SeedEnterprise
Callosum
20 Aug 2026
Callosum unlocks a £75m seed round led by Atomico to optimise AI workloads across the best models and chips
SeedAI

Berkeley SKYDECK

Investment Portfolio

Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs

More venture news

Noggin HQ secures £2.3 million led by Blackfinch Ventures for a credit reference agency built on open banking data

Twin1 AI lands a £15m seed round co-led by VC investors to pair professionals with their own digital twin

Callosum unlocks a £75m seed round led by Atomico to optimise AI workloads across the best models and chips